300760 迈瑞医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入29,484,8057.99%34,931,90130,365,64425,269,58121,025,846
减:营业总成本17,867,2707.97%21,991,20519,826,76016,667,53913,900,566
    其中:营业成本10,358,5235.84%11,820,70810,885,2898,842,7157,366,094
               财务费用(182,371)-69.86%(854,912)(451,037)(85,973)(61,421)
               资产减值损失(161,031)34.13%(529,506)(71,094)(131,734)(110,250)
公允价值变动收益126,883108.56%79,402(21,378)9,879--
投资收益64,217-1,397.18%(9,841)(5,061)811(4,471)
    其中:对联营企业和合营企业的投资收益(14,227)183.20%(9,817)(4,698)811(4,471)
营业利润12,095,3367.99%13,069,85810,990,5159,065,7177,455,160
利润总额12,050,5877.72%13,010,93010,953,5519,017,0857,438,440
减:所得税费用1,347,937-0.26%1,432,5171,342,8341,013,039778,837
净利润10,702,6508.82%11,578,4139,610,7178,004,0466,659,603
减:非控股权益65,5755,267.36%(3,813)3,5432,4921,927
股东净利润10,637,0758.16%11,582,2269,607,1748,001,5546,657,676

市场价值指针
每股收益 (元) *8.7818.12%9.5597.9406.5875.477
每股派息 (元) *5.71032.79%5.8004.5003.5002.500
每股净资产 (元) *30.5940.74%27.28826.37722.17119.148
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见--
回页顶
备注: *未调整数据
#只提供简体内容